Monday, February 01, 2021 8:14:13 AM
6:04 am ET February 1, 2021 (Globe Newswire)
The global wearable robotic exoskeleton market size is projected to reach USD 5,700.9 million by 2027, exhibiting a CAGR of 42.6% during the forecast period. Rising utilization of robotic exoskeletons by healthcare facilities around the world is a prominent factor driving this market, shares Fortune Business Insights(TM) in its report, titled "Wearable Robotic Exoskeleton Market Size, Share & COVID-19 Impact Analysis, By Technology Type (Powered and Passive), By Application (Healthcare, Industrial, Defense & Aerospace and Others) and Regional Forecast, 2020-2027".
In the healthcare industry, wearable robotic exoskeletons are structures designed to aid people suffering from disabilities such as paralysis move their limbs and restore some form of normalcy in their lives. The vast potential of these structures is pushing health facilities worldwide to adopt and utilize them in effective ways. For example, Ekso Bionics' Ekso NR is being used by 300 hospitals across the US. The exoskeleton has been engineered to train the muscles and brains of stroke and spinal cord injury patients and enable them to walk and move again without assistance. In Russia in March 2019, doctors in a Southern Russian hospital used ExoChair, an exoskeleton designed to support the pelvic region and lower limbs, to perform a 12-hour-long urological surgery. The widening adoption of robotic exoskeletons in hospitals is, thus, broadening the horizons of this market.
Recent RWLK News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/04/2024 11:37:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/04/2024 09:39:27 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 08/26/2024 08:14:02 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/15/2024 12:15:14 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2024 09:01:03 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 08/09/2024 08:30:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/06/2024 01:07:40 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 07/29/2024 12:48:04 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 07/19/2024 08:30:30 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/02/2024 09:02:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/02/2024 08:53:43 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/28/2024 08:42:22 PM
- Form SD - Specialized disclosure report • Edgar (US Regulatory) • 05/28/2024 12:30:01 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/15/2024 01:00:51 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/15/2024 12:15:21 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 04/29/2024 12:30:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/22/2024 08:16:29 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 04/22/2024 08:15:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/19/2024 12:46:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/04/2024 01:01:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/03/2024 11:34:09 AM
- VA STAND Act introduced in the United States Senate • GlobeNewswire Inc. • 03/22/2024 12:30:00 PM
- Lifeward Announces Reverse Share Split • GlobeNewswire Inc. • 03/13/2024 03:45:17 PM
- ReStore Exo-Suit Publications Demonstrate Improved Walking Outcomes Versus Conventional Stroke Therapy • GlobeNewswire Inc. • 03/08/2024 01:30:00 PM
- Lifeward announces the Centers for Medicare & Medicaid Services (“CMS”) is deferring its final decision on the payment rate for personal exoskeletons so that more recent claims information on the current, more advanced ReWalk Personal Exoskeleton may b • GlobeNewswire Inc. • 03/01/2024 01:45:11 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM